$XMTR

Cantor Fitzgerald reiterated an Overweight rating and $110 price target for Xometry (XMTR), citing expected earnings above consensus. The company anticipates 33-34% revenue growth, with positive demand trends. XMTR trades at $90.05, up 79% year-over-year. Analysts predict profitability this year, though some suggest overvaluation. Recent Q2 results beat estimates, with 41% revenue growth. Multiple analysts raised price targets to $120.

Xometry Inc (XMTR) shares fell 11.8% to $95.15. Analysts estimate the stock is overvalued by 98% with a GF Value of $48.06. The company has a GF Score of 71, indicating above-average performance but significant overvaluation. Insiders have net sold $15.8M in the past year. The forward P/E ratio is 73.8x, much higher than historical metrics.

Xometry director Randolph Altschuler sold $1.63M in shares on Oct 1-2, 2026, via pre-planned trades. XMTR stock is near its 52-week high, up 99% YoY, but shows negative free cash flow. Q2 2026 earnings beat estimates, with revenue up 41% YoY. Analysts raised price targets to $120 with Buy ratings.

Xometry's CTO sold 1,866 shares worth $192,725 at prices between $101.41 and $105.76, under a 10b5-1 plan. The company's stock is near a 52-week high, up 99% year-over-year. Xometry's Q2 2026 earnings beat estimates, with revenue up 41%. Analysts raised price targets to $120, maintaining buy ratings.

Xometry CEO Sanjeev Sahni sold 1,112 shares for $114,851 under a 10b5-1 plan to cover tax obligations. He holds 179,791 shares. XMTR trades near 52-week high, up 99% YoY. Q2 2026 earnings beat estimates: $0.16 EPS on $229.3M revenue, up 41% YoY. Analysts raised price targets to $120.

Altschuler Randolph sold 5,721 shares of Xometry, Inc. (XMTR) at an average of $103.32 ($101.39–$106.36, $0.59M total) across 6 trades on 2026-10-02 under a Rule 10b5-1 trading plan.

Altschuler Randolph sold 10,000 indirectly-held shares of Xometry, Inc. (XMTR) at an average of $104.04 ($102.55–$106.19, $1.04M total) across 5 trades on 2026-10-01 under a Rule 10b5-1 trading plan.

Xometry officer Sanjeev Singh Sahni plans to sell 1,112 shares worth $116,570.96 on October 2, 2026, according to a regulatory filing. Sahni previously sold 1,500 shares each in August and September 2026, totaling $263,116.80. The shares were acquired through restricted stock units.

Xometry (XMTR) stock has surged 144% in six months, driven by strong Q2 earnings and a Siemens partnership. Q2 revenue was $229.28M, up 41% YoY, beating estimates. Analysts have raised targets to $110, 14% above current price. Insiders have sold $3.46M in stock since July.

Six Montgomery County companies raised over $566 million in Q3. Forbright (Nasdaq) completed an IPO, raising $142.2 million. Xometry (Nasdaq) announced a $225 million secondary offering. RegenxBio (Nasdaq) raised $90.04 million in a public offering. Georgiamune secured $92.69 million in venture funding. Arculus Solutions raised $1.95 million in Seed-1 funding. Jesse & Ben raised $15 million in Series A funding.